» Authors » Paul Hengster

Paul Hengster

Explore the profile of Paul Hengster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 256
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashraf M, Fries D, Streif W, Aigner F, Hengster P, Troppmair J, et al.
Methods Mol Biol . 2015 Dec; 1397:81-90. PMID: 26676129
Methods to monitor the status of a graft prior to transplantation are highly desirable to avoid unnecessary surgical interventions and follow-up treatments and to optimize the clinical outcome as delayed...
2.
Ashraf M, Fries D, Streif W, Aigner F, Hengster P, Troppmair J, et al.
Transpl Int . 2014 Apr; 27(8):868-76. PMID: 24750326
Prolonged ischemia (I) times caused by organ procurement and transport are main contributors to a decrease in organ function, which is further enhanced during reperfusion (R). This combined damage, referred...
3.
Oberhuber R, Mittermair C, Zelger B, Pirkebner D, Draxl A, Weissenbacher A, et al.
Biomed Res Int . 2013 Dec; 2013:975608. PMID: 24324977
Islet transplantation is a valid treatment option for patients suffering from type 1 diabetes mellitus. To assure optimal islet cell quality, specialized islet isolation facilities have been developed. Utilization of...
4.
Aigner E, Felder T, Oberkofler H, Hahne P, Auer S, Soyal S, et al.
J Nutr Biochem . 2012 Jul; 24(1):112-7. PMID: 22819549
Mutual clinical and molecular interactions between iron and glucose metabolism have been reported. We aimed to investigate a potential effect of glucose on iron homeostasis. We found that serum iron...
5.
Hermann M, Wurm M, Lubei V, Pirkebner D, Draxl A, Margreiter R, et al.
Islets . 2012 May; 4(2):152-7. PMID: 22627172
The setup of an islet isolation facility designed along the rules of good manufacturing practice (GMP) is a technically challenging, cost and time intensive process. ( 1) Consequently, several institutions...
6.
Duftner C, Dejaco C, Hengster P, Bijuklic K, Joannidis M, Margreiter R, et al.
PLoS One . 2012 Apr; 7(3):e33939. PMID: 22479483
Background: Pro-inflammatory, cytotoxic CD4(+)CD28(-) T-cells with known defects in apoptosis have been investigated as markers of premature immuno-senescence in various immune-mediated diseases. In this study we evaluated the influence of...
7.
Zenzmaier C, Hermann M, Hengster P, Berger P
Int J Oncol . 2011 Sep; 40(1):40-6. PMID: 21879258
Pancreatic cancer (PaCa) is the fourth leading cause of cancer deaths in Western societies, with pancreatic ductal adenocarcinomas (PDACs) accounting for >90% of such cases. PDAC is a heterogeneous disease...
8.
Hermann M, Nussbaumer O, Knofler R, Hengster P, Nussbaumer W, Streif W
Transfus Med Hemother . 2010 Nov; 37(5):299-305. PMID: 21113254
BACKGROUND: Assessment of platelet vitality is important for patients presenting with inherited or acquired disorders of platelet function and for quality assessment of platelet concentrates. METHODS: Herein we combined live...
9.
Maglione M, Biebl M, Bonatti H, Gobel G, Ratschiller T, Schneeberger S, et al.
Transplantation . 2010 Aug; 90(6):666-71. PMID: 20724959
Background: Risk factors for delayed graft function (DGF) in pancreas transplantation (PTx) and its implications on graft survival are poorly defined. Methods: Eighty-seven consecutive first-time PTx for type I diabetes...
10.
Hermann M, Margreiter R, Hengster P
Adv Exp Med Biol . 2010 Mar; 654:711-24. PMID: 20217521
Human islet transplantation is one of the three treatment modalities besides the daily administration of exogenous insulin and pancreas transplantation, which can be applied for the treatment of type 1...